objective Leishmania major has been considered as the main aetiological agent of cutaneous leishmaniasis in Iran. However, there are recent reports about the existence of Crithidia spp in cutaneous lesions in southern Iran. Therefore, this study was designed to decipher some morphological, biological and molecular aspects of this phenomenon.
Introduction
Cutaneous leishmaniases (CL) are one of the most important vector-borne parasitic diseases and the most common form of leishmaniasis [1, 2] , which is endemic in 88 countries worldwide with more than 90% of cases originating in the Middle East [3] . It is a serious health problem in Iran, as the disease is endemic in 20 of 32 of its provinces with an annual incidence of 20 000-60 000 cases [4, 5] . Unfortunately, the number of leishmaniasis cases is growing and emergence of antimony resistance adds to the complication [6] [7] [8] . Leishmania major is the main aetiological agent of the disease in Iran [9] , but recently, some studies, particularly from southern Iran, reported the existence of lower trypanosomatids in CL lesions [10] [11] [12] . Lower trypanosomatids, such as Crithidia and Leptomonas genera, are referred to as monoxenous parasites vs. Leishmania genus which is considered to be heteroxenous. The former group can only infect invertebrate hosts, such as insects, and is considered nonpathogenic for immunocompetent humans [13] .
Several reports have documented the presence of lower trypanosomatids in immune-deficient patients [14] [15] [16] ; however, most cases of lower trypanosomatids in Iran were derived from immune-competent patients. Therefore, this study was designed to investigate the morphological, biological and molecular characteristics of these unusual parasitic isolates compared with L. major. We applied the whole genome sequence analysis to three clinical cases to expand our understanding of these lower trypanosomatids and gain insight into their potential causative role in CL.
Materials and methods

Clinical isolates
Over the course of 2 years (2013-2015), we enrolled 167 patients suspected of CL from different parts of Fars province, especially Shiraz County, in this study ( Figure 1 , Table 1 ). The research received ethical approval from the Ethics Research Committee of Shiraz University of Medical Sciences and prior consent of the patients. Only patients without any underlying diseases, including immune-deficiency disorders, were enrolled in the study. Samples were collected from the edge of lesions and then two microscopic slides were prepared for morphological and PCR investigation to record the results [17] . At first, samples were cultured in NNN at 25°C and then subcultured in RPMI 1640 (Gibco #11875-093, USA) medium supplemented with 10% foetal calf serum (FCS).
Genus identification
Genus identification was performed using specific primers based on the sequence of GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase) gene in L. major and Crithidia fasciculata. The sequence of GAPDH genes was retrieved from Tritryp genome database. (http://tritrypdb. org/tritrypdb/) and the primers designed by Primer3 software. Recently, it was also approved for diagnosis of leishmaniasis in tissues. These primers have ability to detect not only leishmania spp. but also Crithidia spp. as well [18] . For amplification of GAPDH gene in Leishmania and Crithidia ssp., the following sequences of primers were used respectively: (5 0 ATGGTCAAAGTGGGCATTAACGG3 0 and 3 0 CGCGGATGTGTAGAGAATGAG5 0 ), and (5 0 TCCATGTGCGAGGACAACGTGCT3 0 and 3 0 CGCGTCGTTGATGAAGTCGCT5 0 ). The amplification programme was set to initial denaturation at 94°C for 3 min; followed by 10 cycles each at 95°C for 30 s, 62°C for 30 s and 72°C for 45 s, and a final extension at 72°C for 5 min. Then, the PCR products were visualised on 1.2% agarose gel containing Red Safe (FroggaBio #21141, Canada). The expected amplified fragments 
Morphological analysis
For the light microscopy analysis, for each sample, 10 ll of medium containing stationary phase of promastigotes was spread on a slide, air-dried, and fixed with 100% methanol and stained by 20% Giemsa solution. For comparative microscopic analysis, all slides were examined under 1009 magnification lens and compared with genuine promastigote forms of L. major Fredlien and C. fasciculata as references.
Biological analysis
To estimate the survival capacity of these clinical isolates at 37°C, 10 6 promastigotes in their logarithmic phase were seeded in SDM-79 medium nourished with 20% heat-inactivated foetal calf serum, 5 mg/ml hemin and 10 mM biopterin at pH 7.0 and incubated at 37°C for 3 days. The viability and mobility of cells were investigated daily under invert microscopy and then the morphology of promastigotes was microscopically examined by Giemsa staining after 72 h of incubation at 37°C. Cell viability was tested by subculturing these promastigotes in nourished SDM-79 medium at 25°C. Here, in all experiments, L. major (Acc. # JN860745) and L. infantum (MHOM/MA/67/ITMAP-263) were used as reference strains of Leishmania spp. and one clinical isolate of L. major R004 from Iran was used as a clinical strain of L. major, and C. fasciculata from Centre of Research in Infectious Disease, Laval University was used as a representative strain of lower trypanosomatids.
Macrophage infection assay
A macrophage infection assay was performed to evaluate to what extent these clinical isolates can infect mammalian macrophages in vitro (both J774 and THP1 cell lines) [19] . Briefly, macrophage cells seeded in eightchamber TekLab slides (Sigma-Aldrich Nunc#177445, Germany) were infected with late-stationary promastigotes at a ratio of 20:1 promastigote/macrophage. After 2 h of incubation at 37°C, excessive promastigotes were removed through washing and each well was replaced with fresh complete RPMI-1640 medium containing 10% FBS, 100 U/ml of penicillin, 100 lg/ml of streptomycin, 2 mM. L-glutamine and then incubated at 37°C with 5% CO for 3 days. At the end of the incubation period, Giemsa staining was used to confirm the occurrence of amastigote forms inside the macrophages and the transformation growth assay was used to analyse the survival of amastigotes within the macrophage cells [20] . That is, after three times of extensive washing with 19 HepesNaCl, the macrophage cells were lysed with 0.0125% SDS using a cell scraper (BD Bioscience# 353086, USA). Subsequently, the lysed cells were transferred into a 10 ml tube containing 5 ml 19 Hepes-NaCl and spun down at 3000 rpm for 5 min at 4°C for two times. After that, the extracted parasites were re-suspended in 5 ml SDM-79 medium containing 10% FBS, 100 U/ml of penicillin, 100 lg/ml of streptomycin and biopterin and incubated at 25°C to see the growth of parasites in the form of promastigotes after at least 48 h.
Molecular analysis
To perform karyotype analysis by Pulsed Field Gel Electrophoresis (PFGE), agar blocks containing promastigotes harvested in logarithmic phase of culture were prepared [21] . In brief, 5 9 10 8 /ml cells were re-suspended in 19 HEPES-NaCl buffer and mixed with an equal volume of low melting point agarose (Invitrogen #16520-050, USA). The prepared blocks were transferred to 3 ml of lysis mixture (MLM) containing 0.5 M EDTA (PH 9.5), 1% SLS and proteinase K (333 lg/ml) and were incubated at 50°C overnight. The samples were electrophoresed in 19 TBE buffer by a CHEF-DRIII apparatus (CHEF Mapper, Bio-Rad, US) at 5 V/cm and a 120°C separation angle to separate the range of chromosome between 400 and 1500 kb for 32 h. The separated chromosomes were visualised through ethidium bromide staining. It should be mentioned that PFGE procedure was repeated three times on nine samples including two reference organisms (L. major Friedlin and C. fasciculata) and seven clinical isolates (one L.tropica, three L. major and three Crithidia spp).
Whole genome sequencing
Whole genome sequencing was performed on four samples including one C. fasciculata as a reference parasite of lower trypanosomatids, one clinical strain of L. major (R004) as the reference parasite of Leishmania genus and two clinical isolates of Crithidia spp. identified as (S001 and S002) collected from CL patients. DNAs were extracted from mid-log-phase cultures using a modified phenol extraction method. Briefly, the pellets of promastigotes were re-suspended in suspension buffer (100 mM EDTA, 10 mM Tris, 100 mM NaCl, pH 8.0) and lysed in the presence of 1% SDS with 50 lg/ml proteinase K for 1 h at 37°C. The sample was extracted by one volume of saturated phenol, and DNA in the water phase was precipitated with 2 volumes of 100% ethanol, followed by two washing steps with 70% ethanol and dissolving in 500 ll TE. For elimination of RNAs, RNAse (20 lg/ml) was added to each sample and then they were incubated for 30 min at 37°C. In the next step, 50 lg/ml of proteinase K and 0.1% SDS were added and incubated at 37°C for 30 min. Again, the purified DNA was extracted with 1 volume of phenol, followed by ethanol-precipitating and washing steps and then dissolved in Milli-Q water. The quantity and quality of extracted DNA were measured using a Quantus TM Fluorometer (Promega, USA) and bioanalyzer, respectively.
Next-generation sequencing
Paired-ends sequencing libraries were produced from 50 ng of genomic DNA using the Nextera DNA sample preparation kit (Illumina Inc, San Diego, CA, USA) according to the manufacturer's instructions. The libraries were sequenced on an Illumina Mi-Seq platform with short 250-nucleotide reads, at Research Centre of Infectious Disease, University of Laval.
Data analysis
Reads of sequences were trimmed using the software Trimmomatic. The trimmed sequence reads from each sample were aligned to the reference genomes of C. fasciculata and Leptomonas seymouri which were available at TriTrypDB database (http://tritrypdb.org/tritrypdb/) using the software bwa-mem with default parameters [22] . The maximum number of mismatches was 4, and the seed length was 32 and two mismatches were allowed within the seed. In parallel, the trimmed reads were assembled into contigs using the de novo assembler software Ray with default parameters and a kmer length of 31 nucleotides [23] .
Phylogenetic analysis based on small subunit rRNA (SSU rRNA)
The evolutionary history was inferred using the maximum likelihood method based on the general time reversible model. Initial trees for the heuristic search were obtained automatically by applying the maximum parsimony method. A discrete gamma distribution was used to model evolutionary rate differences among sites (five categories (+G, parameter = 0.1000)). The rate variation model allowed for some sites to be evolutionarily invariable ([+I], 72.0809% sites). The tree was drawn to scale, with branch lengths measured in the number of substitutions per site. The analysis involved 38 nucleotide sequences. All positions with less than 95% site coverage were eliminated. That is, fewer than 5% alignment gaps, missing data and ambiguous bases were allowed at any position. There were a total of 1422 positions in the final data set. Evolutionary analyses were conducted in MEGA6 [24] .
Phylogenetic analysis based on glycosomal GAPDH
The evolutionary history was inferred using the minimum evolution method [25] . The evolutionary distances were computed using the maximum composite likelihood method [26] and were in the units of the number of base substitutions per site. The rate variation among sites was modelled with a gamma distribution (shape parameter = 5). The ME tree was searched using the close-neighbour-interchange (CNI) algorithm at a search level of 1. The neighbour-joining algorithm was used to generate the initial tree. The analysis involved 47 nucleotide sequences. All ambiguous positions were removed for each sequence pair. There were a total of 710 positions in the final data set. Evolutionary analyses were conducted in MEGA6 [25] .
Results
Agent identification
As shown in Table 1 , 167 patients suspected of having CL from different parts of Fars province were studied. Seventy-six were women, 91 were men and most of the patients were 20-60 years old. Hands and face were the most infected areas. A total of 161 patients were infected with L. major, eight had co-infection with Crithidia spp. and four were infected only with Crithidia spp. Most of the patients with Crithidia spp. infection were 40-60 years old and had lesions on their face and legs for more than 8 months. Eight patients were male and four female.
Distinguishing between Leishmania and Crithidia genera in clinical samples
Through amplification of GAPDH gene, among 167 clinical isolates, in 155 cases (92.8%), GAPDH fragments of Leishmania ssp were amplified. In 5.4% of patients (nine isolates), GAPDH genes in both genera were amplified, and in 1.8% of clinical cases (three isolates), only GAPDH gene corresponding to Crithidia spp. was determined (Figures 2 and 3) . Blast analysing of obtained specific PCR fragments revealed that the PCR findings were in complete agreement with GAPDH sequence analysis. All fragments that were generated using specific primers for GAPDH in Crithidia spp. showed high similarity with C. fasciculata (96-98%) and C. lucilata (92-95%), compared with Leishmania spp. (82-86%). Same results were obtained from sequence analysis of GAPDH genes in Leishmania spp.
Morphological analysis
Comparative microscopic examination revealed that clinical isolates of lower trypanosomatid promastigotes were clearly different from Leishmania spp. and similar to C. fasciculata (Figure 4) . The majority of Crithidia promastigotes were slender, shorter and had blunt ends with a denser kinetoplast located closer to the nucleus than promastigotes of Leishmania spp. Also, Crithidia isolates grew more rapidly than Leishmania spp. isolates.
Biological analysis
We observed that clinical isolates of C. fasciculata could survive at human body temperature, but the reference parasites of C. fasciculata could not withstand this temperature; all its promastigotes degenerated in this condition. In contrast, promastigotes of L. major Friedlin (as a reference parasite) and clinical isolates of L. major (R004) were totally alive, active and in good shape. Although clinical isolates of Crithidia survived at this temperature, they were less active and rounder than promastigotes of L. major strains ( Figure 5 ).
Macrophage infection assay
During infecting macrophages with C. fasciculata (reference organism), no amastigote form was found in infected macrophage cells and therefore, no promastigote form was retrieved after transformation assay. On the contrary, the reference strains L. major Friedlin and L. infantum (MHOM/MA/67/ITMAP-263) showed a high rate of macrophage infection and good propagation of promastigotes after macrophage infection assay. Surprisingly, all clinical cases (L. major and Crithidia spp.) could infect both cell lines of macrophages and growth of promastigotes occurred after transformation assay. However, the percentage of infection was significantly lower in the field strains than in reference strains, and it was much less in clinical isolates of Crithidia spp. than in clinical isolate of L. major R004 ( Figure 6 ).
Molecular analysis
Pulsed Field Gel Electrophoresis was an effective approach to reveal karyotype patterns of these clinical isolates. Clinical cases of Crithidia showed totally different chromosomal pattern than Leishmania spp. but also a little difference between chromosomal patterns of C. fasciculata (reference organism) and other clinical isolates of Crithidia was noted.
Whole genome sequencing
We ran sequence analysis by comparing the obtained sequencing data with every reference genome downloaded from tritrypdb including Leishmania spp., C. fasciculata and Leptomonas seymouri. As the analysis was specific at the species-level, the C. fasciculata as a representative reference isolate gave a clear positive signal with genome of C. fasciculata, and the clinical isolate of L. major (R004) also showed a potential positive signal to L. major. Intriguingly, both clinical isolates of Crithidia (S001 and S002) which were expected to be C. fasciculata based on GAPDH gene sequence showed no similarity with any of included reference genomes, not even to C. fasciculata (Figure 7 ).
L. major L. infantum C. fasciculata
Isolate like -crithidia Figure 5 The comparative analysis of survival capacity of promastigotes cultivated at 37°C during 3 days (Giemsa staining, magnification 10009). The alive promastigotes of Leishmania major (R004) could be clearly compared with degenerated cells of Crithidia fasciculata, and also it would be comparable with alive and more round promastigote forms L.infantum (MHOM/MA/67/ITMAP-263) and clinical isolate of Crithidia (S002), (Giemsa staining, magnification 10009). [Colour figure can be viewed at wileyonlinelibrary.com].
C. fasciculata L. major L. major from field
Isolate like-Crithidia
Isolate like-Crithidia Figure 6 A sample of macrophage-amastigote assay using cell line (THP1). The arrows indicated intracellular parasites (amastigotes) which could be seen in (Leishmania major Friedlin), clinical isolates of L. major (R004) and Crithidia (S1and S002). While no amastigote form could be observed inside macrophages infected with C. fasciculate. Arrows indicated amastigote forms, (Giemsa staining, magnification 10009).
[Colour figure can be viewed at wileyonlinelibrary.com].
Phylogenetic analysis based on sequences of SSU rRNA and glycosomal GAPDH In this study, two loci SSU rRNA and glycosomal GAPDH were used for independent phylogenies. SSU rRNA usually enables differentiating between genera and so herein, it was obvious that Leishmania and Crithidia genera were well-separated and gGAPDH phylogenetic would be a useful gene for differentiating the species. Overall, the phylogenetic analysis confirmed that two clinical isolates of Crithidia (S001 and S002) were part of the Crithidia genus (Figure 7) . Although the phylogenetic was not clear enough for attributing these Crithidia isolates to a specific species, they clearly clustered with C. fasciculata and C. luciliae (Figure 8 ). The clinical isolates included were Leishmania major R004, Crithidia isolates (S1 and S002) and Crithidia fasciculata (MOU) refers to reference strain which sequenced in this study along with clinical isolates. large, acute and swollen lesion ( Figure 9 ). Morphological characteristics of most lesions were the same as zoonotic leishmaniasis. GAPDH gene sequencing and microscopic examination revealed that clinical strains of Crithidia appeared to be like C. fasciculata; although they presented some biological features similar to Leishmania spp. (i.e. surviving at human body temperature and infecting mammalian macrophage cells). According to phylogenetic analysis, these clinical strains of Crithidia were not part of the genus Leishmania and were close to C. fasciculata; and based on whole genome sequencing, they were not C. fasciculata and might have been another species.
These intriguing findings could be discussed in several aspects. Opportunistic infections in humans with lower trypanosomatids (such as Herpetomonas and Leptomonas) have mostly been reported in immune-deficient patients [15, 27, 28] . But in this study, Crithidia organisms were separated from lesions in immune-competent patients with no underlying diseases. Consistent with our observation, there is a recent report from India indicating Figure 8 The evolutionary history was inferred using the minimum evolution method among Leishmania and lower trypanosomatids using glycosomal GAPDH sequences. The optimal tree with the sum of branch length = 1.34696826 is shown. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to the branches. The clinical isolates included were Leishmania major R004, Crithidia isolates (S1 and S002) and Crithidia fasciculata (MOU) refers to reference strain which sequenced in this study along with clinical isolates. the occurrence of Leptomonas.symori as a lower trypanosomatids in visceral leishmaniasis patients [29, 30] . Sing et al. [31] reported that after whole genome sequencing, only L. symori was isolated from the spleen of some immune-competent patients with visceral leishmaniasis.
In our study, some Crithidia spp. were isolated from lesions of CL patients. Some possible explanations can be provided for this observation. Indeed, one could argue that the media might have become contaminated with Crithidia spp. during laboratory; however, there was no source of lower trypanosomatids in our primary laboratory and more importantly, all PCR tests were repeated on the slides directly prepared from patients' ulcers. In addition, our observation of co-infection cases agrees with two recent publications from Iran. In one report, a clinical case of CL was found with co-infections of L. major, L. tropica and C. fasciculata by analysing the sequence of ITS-rDNA gene [12] . And more recently, Doudi et al. [11] reported the existences of Crithidia spp. in several CL patients based on ITS1 sequencing in clinical isolates. These studies were performed in endemic regions close to our research area. Therefore, it seems that there are frequent co-existences of Crithidia spp. in clinical cases of CL at least in southern Iran. Although further studies are needed to test whether these coinfections are geographically limited to this specific region or can be found in other endemic regions as well. Another question is that to what extent these clinical isolates of Crithidia spp. can change the clinical manifestations and treatment outcomes of CL. Our observations indicate that all clinical cases with Crithidia spp. showed more severe and chronic forms of the disease compared with cases which were only infected with leishmania spp. (Figure 9 ). Also, half of the patients with co-infection of Leishmania spp. and Crithidia spp. (five out of 10) were unresponsive to Glucantime R (the first line drug in treatment of Cl in Iran). In view of increasing reports of Glucantime R resistance and severe cases of CL, especially in southern Iran [32, 33] , it would be interesting to decipher any links between drug resistance and clinical manifestations with the presence of Crithidia spp. in lesions of these patients.
In two patients, we could only isolate Crithidia spp. in the lesions (Figure 10 ). One possible explanation would be that this non-pathogenic parasite may develop biological adaptations and capacities to survive in vertebrate hosts. However, finding enough evidence that can [further] prove the Crithidia spp. as a pathogenic agent will undoubtedly require more comprehensive experimental and clinical analysis. Bhattarari et al. reported the coexistences of Leptomonas spp. and L. donovani in some Phlebotomus spp. that were responsible in transmission of Leishmania spp. to human in Nepal and India. Thus, it seems possible that sand flies are involved in transmission of lower trypanosomatids to humans the way they are involved in transmission of Leishmania. spp. [34] , although we could not find any epidemiological reports about the potential vectors of CL in Iran.
Conclusion
Our study confirmed that Crithidia spp. occurs in lesions of patients suffering from CL in Iran. Further epidemiological studies on both CL patients and vectors in different endemic regions of Iran are warranted to gain a better understanding of this phenomenon, as this finding might impact leishmaniasis pathogenicity, therapeutic outcomes and disease control strategies.
